FDA Warns of Cough Syrup Contamination
Consumers should stop use and report any adverse events.
The FDA has issued a warning to consumers regarding the use of Rompe Pecho EX and Rompe Pecho CF cough syrups.
According to a drug safety communication issued by the agency, the cough syrups for children six years of age and older may have become microbially contaminated at its manufacturing facility, Efficient Laboratories, Inc. At the time of this release, the FDA says they are not aware of any adverse events with these particular medicines.
Trending: The 10 Best-and Worst-States for Vaccinations
Consumers are advised to suspend use and dispose of the medications; Efficient Laboratories has also received a recommendation from the FDA to voluntarily recall the products.
Patients can report any adverse events and/or quality problems to MedWatch’s Adverse Event Reporting program.
- Complete and submit the report online; or
- Download and complete the form, then submit it via fax at 1-800-FDA-0178
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
